NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 3 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $11,000 | -21.4% | 21,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $14,000 | +16.7% | 21,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $12,000 | -52.0% | 21,000 | +10.5% | 0.00% | -50.0% |
| Q4 2019 | $25,000 | -51.9% | 19,000 | -27.3% | 0.00% | -60.0% |
| Q3 2019 | $52,000 | -70.6% | 26,150 | -64.1% | 0.01% | -72.2% |
| Q2 2019 | $177,000 | -22.7% | 72,800 | -22.3% | 0.02% | -28.0% |
| Q1 2019 | $229,000 | +51.7% | 93,750 | -9.5% | 0.02% | +31.6% |
| Q4 2018 | $151,000 | -39.4% | 103,550 | +12.5% | 0.02% | -32.1% |
| Q3 2018 | $249,000 | -32.9% | 92,050 | -13.6% | 0.03% | -39.1% |
| Q2 2018 | $371,000 | – | 106,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |